-
公开(公告)号：US20160206801A1
公开(公告)日：2016-07-21
申请号：US15067559
申请日：2016-03-11
Applicant: Medtronic, Inc.
Inventor： Martin Gerber , Suping Lyu , Bryant Pudil
CPC classification number: A61M1/1603 , A61B5/0031 , A61B5/026 , A61B5/0295 , A61B5/053 , A61B5/0537 , A61B5/145 , A61B5/14503 , A61B5/14535 , A61B5/14539 , A61B5/14546 , A61B5/4836 , A61B5/4848 , A61B5/6866 , A61B2560/0223 , A61M1/00 , A61M1/14 , A61M1/16 , A61M1/1601 , A61M1/1605 , A61M1/1607 , A61M1/1613 , A61M1/28 , A61M1/34 , A61M1/3403 , A61M1/342 , A61M1/3607 , A61M1/3609 , A61M1/361 , A61M1/3612 , A61M2205/04 , A61M2205/18 , A61M2205/33 , A61M2205/3303 , A61M2205/3306 , A61M2205/3313 , A61M2205/3331 , A61M2205/3334 , A61M2205/3375 , A61M2205/3523 , A61M2205/50 , A61M2205/52 , A61M2205/60 , A61M2205/70 , A61M2230/00 , A61M2230/005 , A61M2230/20 , A61M2230/207 , A61M2230/208 , A61M2230/65 , B01D61/00 , B01D61/32 , B01D65/02 , B01D2321/12 , B01D2321/40 , G06F19/00
Abstract: Monitoring of the performance of a blood fluid removal medium of a blood fluid removal device includes monitoring of condition, such as fluid flow rate or concentration of blood waste product, downstream of the medium. Upstream monitoring of the condition may also be performed to enhance the ability to determine whether the blood fluid removal medium is performing within predetermined ranges.
Abstract translation: 监测血液流体去除装置的血液流体去除介质的性能包括在介质下游监测诸如流体流动速率或血液废物产物浓度的状况。 还可以进行条件的上游监视，以增强确定血液流体去除介质是否在预定范围内执行的能力。
-
公开(公告)号：USD714455S1
公开(公告)日：2014-09-30
申请号：US29446281
申请日：2013-02-21
Applicant: Medtronic, Inc.
Designer： Martin Gerber , David Lura , Bryant Pudil , Thomas Meyer , Brian Mullins
-
公开(公告)号：US10293092B2
公开(公告)日：2019-05-21
申请号：US14828990
申请日：2015-08-18
Applicant: Medtronic, Inc.
Inventor： Martin Gerber , John Burnes , Suping Lyu , VenKatesh R. Manda , Bryant Pudil
IPC: A61M1/16 , A61M1/34 , A61M1/36 , A61B5/145 , A61B5/00 , A61B5/026 , A61B5/053 , B01D65/02 , A61M1/00 , A61B5/0295 , A61M1/14 , B01D61/00 , B01D61/32 , A61M1/28 , G06F19/00
Abstract: Methods include monitoring indicators of blood pH or blood electrolyte levels during a blood fluid removal session and adjusting concentrations of pH buffers or electrolytes in dialysate or replacement fluid used during the session based on the monitored indicators. Blood fluid removal systems may employ sensors that monitor blood pH or electrolyte levels to adjust the fluid parameters during a blood fluid removal session.
-
公开(公告)号：US10179198B2
公开(公告)日：2019-01-15
申请号：US14828979
申请日：2015-08-18
Applicant: Medtronic, Inc.
Inventor： Martin Gerber , John Burnes , Suping Lyu , VenKatesh R. Manda , Bryant Pudil
IPC: A61M1/16 , A61M1/34 , A61M1/36 , A61B5/145 , A61B5/00 , A61B5/026 , A61B5/053 , B01D65/02 , A61M1/00 , A61B5/0295 , A61M1/14 , B01D61/00 , B01D61/32 , A61M1/28 , G06F19/00
Abstract: Methods include monitoring indicators of blood pH or blood electrolyte levels during a blood fluid removal session and adjusting concentrations of pH buffers or electrolytes in dialysate or replacement fluid used during the session based on the monitored indicators. Blood fluid removal systems may employ sensors that monitor blood pH or electrolyte levels to adjust the fluid parameters during a blood fluid removal session.
-
公开(公告)号：US09642960B2
公开(公告)日：2017-05-09
申请号：US14554272
申请日：2014-11-26
Applicant: Medtronic, Inc.
Inventor： Martin Gerber , John Burnes , Suping Lyu , Manda R. VenKatesh , Bryant Pudil
IPC: A61M37/00 , A61M1/16 , A61B5/145 , A61B5/00 , A61B5/026 , A61B5/053 , A61M1/34 , B01D65/02 , A61M1/00 , A61B5/0295 , A61M1/14 , B01D61/00 , B01D61/32 , A61M1/36 , A61M1/28
CPC classification number: A61M1/1603 , A61B5/0031 , A61B5/026 , A61B5/0295 , A61B5/053 , A61B5/0537 , A61B5/145 , A61B5/14503 , A61B5/14535 , A61B5/14539 , A61B5/14546 , A61B5/4836 , A61B5/4848 , A61B5/4875 , A61B5/6866 , A61B5/7282 , A61B2560/0223 , A61M1/00 , A61M1/14 , A61M1/16 , A61M1/1601 , A61M1/1605 , A61M1/1607 , A61M1/1613 , A61M1/28 , A61M1/34 , A61M1/3403 , A61M1/342 , A61M1/3607 , A61M1/3609 , A61M1/361 , A61M1/3612 , A61M1/3672 , A61M2202/0498 , A61M2205/04 , A61M2205/18 , A61M2205/33 , A61M2205/3303 , A61M2205/3306 , A61M2205/3313 , A61M2205/3331 , A61M2205/3334 , A61M2205/3375 , A61M2205/3523 , A61M2205/50 , A61M2205/502 , A61M2205/52 , A61M2205/60 , A61M2205/70 , A61M2230/00 , A61M2230/005 , A61M2230/06 , A61M2230/20 , A61M2230/207 , A61M2230/208 , A61M2230/65 , B01D61/00 , B01D61/32 , B01D65/02 , B01D2321/12 , B01D2321/40 , G06F19/00
Abstract: A method includes monitoring an indicator of fluid volume of a patient via a sensor device, and setting an initial fluid volume removal prescription for a blood fluid removal session based on the monitored indicator of fluid volume. The method may further include transmitting data regarding the indicator of fluid volume from the implantable sensor device to fluid removal device. The system includes a blood fluid removal device configured to set the initial fluid removal volume and rate prescription. In some embodiments, the fluid removal device sets or calculated the initial fluid volume removal prescription based on the data received from the implantable sensor. The indicator of fluid volume may be an indicator of tissue fluid volume or an indicator of blood fluid volume.
-
Patent Agency Ranking
公开(公告)号：US20170361006A1
公开(公告)日：2017-12-21
申请号：US15693535
申请日：2017-09-01
Applicant: Medtronic, Inc.
Inventor： Martin Gerber , John Burnes , SuPing Lyu , VenKatesh R. Manda , Bryant Pudil
IPC: A61M1/16 , A61M1/36 , A61B5/00 , A61B5/026 , A61B5/0295 , A61M1/28 , A61B5/145 , A61M1/00 , A61M1/14 , B01D65/02 , B01D61/32 , B01D61/00 , A61M1/34 , A61B5/053
Abstract: Methods for monitoring patient parameters and blood fluid removal system parameters include identifying those system parameters that result in improved patient parameters or in worsened patient parameters. By comparing the patient's past responses to system parameters or changes in system parameters, a blood fluid removal system may be able to avoid future use of parameters that may harm the patient and may be able to learn which parameters are likely to be most effective in treating the patient in a blood fluid removal session.
-
公开(公告)号：US09597440B2
公开(公告)日：2017-03-21
申请号：US14613725
申请日：2015-02-04
Applicant: Medtronic, Inc.
Inventor： Martin Gerber , John Burnes , Suping Lyu , VenKatesh R. Manda , Bryant Pudil
IPC: A61M37/00 , C02F1/44 , A61M1/16 , A61B5/145 , A61B5/00 , A61B5/026 , A61B5/053 , A61M1/34 , B01D65/02 , A61M1/00 , A61B5/0295 , A61M1/14 , B01D61/00 , B01D61/32 , A61M1/36 , A61M1/28
CPC classification number: A61M1/1603 , A61B5/0031 , A61B5/026 , A61B5/0295 , A61B5/053 , A61B5/0537 , A61B5/145 , A61B5/14503 , A61B5/14535 , A61B5/14539 , A61B5/14546 , A61B5/4836 , A61B5/4848 , A61B5/4875 , A61B5/6866 , A61B5/7282 , A61B2560/0223 , A61M1/00 , A61M1/14 , A61M1/16 , A61M1/1601 , A61M1/1605 , A61M1/1607 , A61M1/1613 , A61M1/28 , A61M1/34 , A61M1/3403 , A61M1/342 , A61M1/3607 , A61M1/3609 , A61M1/361 , A61M1/3612 , A61M1/3672 , A61M2202/0498 , A61M2205/04 , A61M2205/18 , A61M2205/33 , A61M2205/3303 , A61M2205/3306 , A61M2205/3313 , A61M2205/3331 , A61M2205/3334 , A61M2205/3375 , A61M2205/3523 , A61M2205/50 , A61M2205/502 , A61M2205/52 , A61M2205/60 , A61M2205/70 , A61M2230/00 , A61M2230/005 , A61M2230/06 , A61M2230/20 , A61M2230/207 , A61M2230/208 , A61M2230/65 , B01D61/00 , B01D61/32 , B01D65/02 , B01D2321/12 , B01D2321/40 , G06F19/00
Abstract: A method includes initiating a blood fluid removal session of a patient; monitoring an indicator of tissue fluid volume of the patient, or a portion thereof, during the blood fluid removal session; monitoring an indicator of blood fluid volume of the patient during the blood fluid removal session; determining whether a ratio of the indicator of tissue fluid volume to indicator of blood fluid volume is outside of a predetermined range; and altering the rate of fluid removal during the blood fluid removal session if the ratio is determined to be outside of the predetermined range. A blood fluid removal system may be configured to carry out the method.
-
公开(公告)号：US20150367054A1
公开(公告)日：2015-12-24
申请号：US14828990
申请日：2015-08-18
Applicant: Medtronic, Inc.
Inventor： Martin Gerber , John Burnes , Suping Lyu , VenKatesh R. Manda , Bryant Pudil
CPC classification number: A61M1/1601 , A61B5/0031 , A61B5/026 , A61B5/0295 , A61B5/053 , A61B5/0537 , A61B5/145 , A61B5/14503 , A61B5/14535 , A61B5/14539 , A61B5/14546 , A61B5/4836 , A61B5/4848 , A61B5/4875 , A61B5/6866 , A61B5/7282 , A61B2560/0223 , A61M1/00 , A61M1/14 , A61M1/16 , A61M1/1603 , A61M1/1605 , A61M1/1607 , A61M1/1613 , A61M1/28 , A61M1/34 , A61M1/3403 , A61M1/342 , A61M1/3607 , A61M1/3609 , A61M1/361 , A61M1/3612 , A61M1/3672 , A61M2202/0498 , A61M2205/04 , A61M2205/18 , A61M2205/33 , A61M2205/3303 , A61M2205/3306 , A61M2205/3313 , A61M2205/3331 , A61M2205/3334 , A61M2205/3375 , A61M2205/3523 , A61M2205/50 , A61M2205/502 , A61M2205/52 , A61M2205/60 , A61M2205/70 , A61M2230/00 , A61M2230/005 , A61M2230/06 , A61M2230/20 , A61M2230/207 , A61M2230/208 , A61M2230/65 , B01D61/00 , B01D61/32 , B01D65/02 , B01D2321/12 , B01D2321/40 , G06F19/00
Abstract: Methods include monitoring indicators of blood pH or blood electrolyte levels during a blood fluid removal session and adjusting concentrations of pH buffers or electrolytes in dialysate or replacement fluid used during the session based on the monitored indicators. Blood fluid removal systems may employ sensors that monitor blood pH or electrolyte levels to adjust the fluid parameters during a blood fluid removal session.
-
公开(公告)号：US20150352269A1
公开(公告)日：2015-12-10
申请号：US14828979
申请日：2015-08-18
Applicant: MEDTRONIC, INC.
Inventor： Martin Gerber , John Burnes , Suping Lyu , VenKatesh R. Manda , Bryant Pudil
IPC: A61M1/16
CPC classification number: A61M1/1601 , A61B5/0031 , A61B5/026 , A61B5/0295 , A61B5/053 , A61B5/0537 , A61B5/145 , A61B5/14503 , A61B5/14535 , A61B5/14539 , A61B5/14546 , A61B5/4836 , A61B5/4848 , A61B5/4875 , A61B5/6866 , A61B5/7282 , A61B2560/0223 , A61M1/00 , A61M1/14 , A61M1/16 , A61M1/1603 , A61M1/1605 , A61M1/1607 , A61M1/1613 , A61M1/28 , A61M1/34 , A61M1/3403 , A61M1/342 , A61M1/3607 , A61M1/3609 , A61M1/361 , A61M1/3612 , A61M1/3672 , A61M2202/0498 , A61M2205/04 , A61M2205/18 , A61M2205/33 , A61M2205/3303 , A61M2205/3306 , A61M2205/3313 , A61M2205/3331 , A61M2205/3334 , A61M2205/3375 , A61M2205/3523 , A61M2205/50 , A61M2205/502 , A61M2205/52 , A61M2205/60 , A61M2205/70 , A61M2230/00 , A61M2230/005 , A61M2230/06 , A61M2230/20 , A61M2230/207 , A61M2230/208 , A61M2230/65 , B01D61/00 , B01D61/32 , B01D65/02 , B01D2321/12 , B01D2321/40 , G06F19/00
Abstract: Methods include monitoring indicators of blood pH or blood electrolyte levels during a blood fluid removal session and adjusting concentrations of pH buffers or electrolytes in dialysate or replacement fluid used during the session based on the monitored indicators. Blood fluid removal systems may employ sensors that monitor blood pH or electrolyte levels to adjust the fluid parameters during a blood fluid removal session.
Abstract translation: 方法包括监测血液流体清除过程中血液pH值或血液电解质水平的指标，并根据监测的指标调整会话期间使用的透析液或替代液体中pH缓冲液或电解质的浓度。 血液清除系统可以使用监测血液pH值或电解质水平的传感器，以在血液清除期间调整流体参数。
-
公开(公告)号：US20150080682A1
公开(公告)日：2015-03-19
申请号：US14554338
申请日：2014-11-26
Applicant: Medtronic, Inc.
Inventor： Martin Gerber , John Burnes , Suping Lyu , Manda R. VenKatesh , Bryant Pudil
CPC classification number: A61M1/1603 , A61B5/0031 , A61B5/026 , A61B5/0295 , A61B5/053 , A61B5/0537 , A61B5/145 , A61B5/14503 , A61B5/14535 , A61B5/14539 , A61B5/14546 , A61B5/4836 , A61B5/4848 , A61B5/4875 , A61B5/6866 , A61B5/7282 , A61B2560/0223 , A61M1/00 , A61M1/14 , A61M1/16 , A61M1/1601 , A61M1/1605 , A61M1/1607 , A61M1/1613 , A61M1/28 , A61M1/34 , A61M1/3403 , A61M1/342 , A61M1/3607 , A61M1/3609 , A61M1/361 , A61M1/3612 , A61M1/3672 , A61M2202/0498 , A61M2205/04 , A61M2205/18 , A61M2205/33 , A61M2205/3303 , A61M2205/3306 , A61M2205/3313 , A61M2205/3331 , A61M2205/3334 , A61M2205/3375 , A61M2205/3523 , A61M2205/50 , A61M2205/502 , A61M2205/52 , A61M2205/60 , A61M2205/70 , A61M2230/00 , A61M2230/005 , A61M2230/06 , A61M2230/20 , A61M2230/207 , A61M2230/208 , A61M2230/65 , B01D61/00 , B01D61/32 , B01D65/02 , B01D2321/12 , B01D2321/40 , G06F19/00
Abstract: A method includes monitoring an indicator of fluid volume of a patient via a sensor device, and setting an initial fluid volume removal prescription for a blood fluid removal session based on the monitored indicator of fluid volume. The method may further include transmitting data regarding the indicator of fluid volume from the implantable sensor device to fluid removal device. The system includes a blood fluid removal device and control electronics configured to set the initial fluid removal volume and rate prescription. In some embodiments, the fluid removal device sets or calculated the initial fluid volume removal prescription based on the data received from the implantable sensor. The indicator of fluid volume may be an indicator of tissue fluid volume or an indicator of blood fluid volume.
Abstract translation: 一种方法包括通过传感器装置监测患者的流体体积的指示器，以及基于所监视的流体体积的指示器设定用于血液流体清除会话的初始流体体积去除处方。 该方法还可以包括将关于流体体积指示器的数据从可植入传感器装置传送到流体移除装置。 该系统包括血液流体清除装置和配置成设置初始流体去除体积和速率处方的控制电子装置。 在一些实施例中，流体移除装置基于从可植入传感器接收的数据设置或计算初始流体体积去除处方。 流体体积的指标可以是组织液体体积的指标或血液体积的指标。
-
-
-
-
-
-
-
-
-
Search Results
22
records
(took 0.018 seconds)
